Roux-en-Y gastric bypass surgery improves hepatic glucose metabolism and reduces plasma Kisspeptin levels in morbidly obese patients with type 2 diabetes.

CONCLUSION: Improved hepatic glucose metabolism and lower plasma kisspeptin in T2D after RYGB may link improved hepatic function with enhanced insulin responsiveness after surgery. PMID: 31709832 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31709832?dopt=Abstract

Source: Am J Physiol Gastroi... - November 10, 2019 Category: Gastroenterology Authors: Flynn CR, Albaugh VL, Tamboli RA, Gregory JM, Bosompem A, Sidani RM, Winnick JJ Tags: Am J Physiol Gastrointest Liver Physiol Source Type: research